Cargando…

Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial

INTRODUCTION: Genetic testing for hypertrophic cardiomyopathy (HCM) in the era of genomics brings unique challenges for genetic counselling. The number of genes routinely included in an HCM gene panel has increased markedly, many with minimal if any robust evidence of gene–disease association. Subse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burns, Charlotte, Yeates, Laura, Semsarian, Christopher, Ingles, Jodie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361342/ https://www.ncbi.nlm.nih.gov/pubmed/30782759 http://dx.doi.org/10.1136/bmjopen-2018-026627

Ejemplares similares

Development of a communication aid for explaining hypertrophic cardiomyopathy genetic test results
por: Smagarinsky, Yana, et al.
Publicado: (2017)

Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers
por: Sweeting, Joanna, et al.
Publicado: (2016)

Rare desmin variant causing penetrant life-threatening arrhythmic cardiomyopathy
por: Oomen, Ad W.G.J., et al.
Publicado: (2018)

Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment
por: Butters, Alexandra, et al.
Publicado: (2021)

Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial
por: Shickh, Salma, et al.
Publicado: (2018)

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
por: Marston, Nicholas A, et al.
Publicado: (2021)

Needs analysis of parents following sudden cardiac death in the young
por: McDonald, Kristie, et al.
Publicado: (2020)

LAMP2 shines a light on cardiomyopathy in an athlete
por: Martin, Sophie, et al.
Publicado: (2017)

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes
por: Ingles, Jodie, et al.
Publicado: (2019)

Case Report: A Chinese Family of Hypertrophic Cardiomyopathy Caused by a Novel Splicing Mutation in the FLNC Gene
por: Huang, Chunhui, et al.
Publicado: (2022)

Clinical and genetic features of Australian families with long QT syndrome: A registry-based study
por: Burns, Charlotte, et al.
Publicado: (2016)

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
por: Lloyd, Rachael, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry
por: Marstrand, Peter, et al.
Publicado: (2020)

Systemic Bioinformatic Analyses of Nuclear-Encoded Mitochondrial Genes in Hypertrophic Cardiomyopathy
por: Tan, Zhaochong, et al.
Publicado: (2021)

Molecular autopsy in victims of inherited arrhythmias
por: Semsarian, Christopher, et al.
Publicado: (2016)

Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays
por: de Wit, N J W, et al.
Publicado: (2005)

Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy
por: Gupta, Ishita, et al.
Publicado: (2018)

Corrigendum: Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy
por: Gupta, Ishita, et al.
Publicado: (2018)

The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication
por: Harris, Stephanie, et al.
Publicado: (2019)

A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial
por: van den Heuvel, Lieke M, et al.
Publicado: (2019)

Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol
por: Monserrat Villatoro, Jaime, et al.
Publicado: (2020)

Randomised double-blind controlled trial of non-invasive preimplantation genetic testing for aneuploidy in in vitro fertilisation: a protocol paper
por: Cheng, Hiu Yee Heidi, et al.
Publicado: (2023)

Using codesign focus groups to develop an online COmmunity suPporting familiEs after Sudden Cardiac Death (COPE-SCD) in the young
por: Yeates, Laura, et al.
Publicado: (2022)

Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery
por: Shickh, Salma, et al.
Publicado: (2022)

The Australian Genetic Heart Disease Registry: Protocol for a Data Linkage Study
por: Butters, Alexandra, et al.
Publicado: (2023)

Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial
por: Hernandez-Suarez, Dagmar F, et al.
Publicado: (2020)

Getting inside the engine - myosin modulation in hypertrophic cardiomyopathy and systolic heart failure
por: Daniels, Matthew J, et al.
Publicado: (2021)

Relations between right ventricular morphology and clinical, electrical and genetic parameters in Brugada Syndrome
por: Gray, Belinda, et al.
Publicado: (2018)

Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy
por: Li, Yao, et al.
Publicado: (2022)

Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial
por: Shickh, Salma, et al.
Publicado: (2019)

IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort
por: DeLellis, K, et al.
Publicado: (2003)

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
por: Litt, Michael J, et al.
Publicado: (2023)

Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
por: Helms, Adam S., et al.
Publicado: (2020)

Familial association of pancreatic cancer with other malignancies in Swedish families
por: Hiripi, E, et al.
Publicado: (2009)

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy
por: Farrant, John, et al.
Publicado: (2023)

Two-step offer and return of multiple types of additional genomic findings to families after ultrarapid trio genomic testing in the acute care setting: a study protocol
por: Bouffler, Sophie E, et al.
Publicado: (2023)

Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation
por: Thompson, Andrea D., et al.
Publicado: (2021)

Case Report: Two New Cases of Autosomal-Recessive Hypertrophic Cardiomyopathy Associated With TRIM63-Compound Heterozygous Variant
por: Andreeva, Sofiya, et al.
Publicado: (2022)

Sparse dimensionality reduction approaches in Mendelian randomisation with highly correlated exposures
por: Karageorgiou, Vasileios, et al.
Publicado: (2023)

Routinely collected health data to study inherited heart disease: a systematic review (2000–2016)
por: Blanch, Bianca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_11bh3889r2um5c1pvc3eal7n03